
Pfizer, Blackstone Life Sciences Enter Strategic Funding Agreement for GLP-1
The new $1.5 billion funding agreement will support the clinical development of an investigational monthly injection being studied for chronic weight management and obesity-related comorbidities, including OSA.
Sleep Review
